Join former FDA commissioners to explore the ways in which real-world evidence can support both regulatory decision-making and value-based payment programs.
Congress took an important step to bring safe and effective treatments and cures to patients by passing the Food and Drug Administration (FDA) Reauthorization Act of 2017.
Improving Patient Safety and Information Technology Calls for Greater Leadership, Collaboration, and a Systems-Based Approach
BPC’s new report outlines recommendations for improving health IT’s role in providing safer care for patients while promoting innovation.
The Bipartisan Policy Center applauds the Senate HELP Committee for passing the Food and Drug Administration Reauthorization Act of 2017.
The bill provides a $2 billion increase in funding for the National Institutes of Health (NIH) to support important research.
Timely completion and passage of FDA user fee reauthorization legislation is a crucial next step toward helping Americans in need.
The bigger concern is the fact that it takes more than ten years and $2 billion to develop a new drug from a molecule to a medicine.
The legislation will advance groundbreaking medical innovation and research that will help millions of Americans with life-threatening diseases.